10 20 30 40 50 60 70 80 1PQC - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSCRIPTION REGULATION 18-JUN-03 1PQC
TITLE HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317
COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYSTEROLS RECEPTOR LXR-BETA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 213-261; COMPND 5 SYNONYM: LIVER X RECEPTOR BETA, NUCLEAR ORPHAN RECEPTOR COMPND 6 LXR-BETA, UBIQUITOUSLY-EXPRESSED NUCLEAR RECEPTOR, NUCLEAR COMPND 7 RECEPTOR NER; COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H2 OR LXRB OR UNR OR NER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 STAR (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A
KEYWDS LXRB+T0901317, TRANSCRIPTION REGULATION
EXPDTA X-RAY DIFFRACTION
AUTHOR M.FARNEGARDH,T.BONN,S.SUN,J.LJUNGGREN,H.AHOLA,A.WILHELMSSON, AUTHOR 2 J.-A.GUSTAFSSON,M.CARLQUIST
REVDAT 4 31-MAR-09 1PQC 1 REVDAT REVDAT 3 24-FEB-09 1PQC 1 VERSN REVDAT 2 25-NOV-03 1PQC 1 JRNL REVDAT 1 09-SEP-03 1PQC 0
JRNL AUTH M.FARNEGARDH,T.BONN,S.SUN,J.LJUNGGREN,H.AHOLA, JRNL AUTH 2 A.WILHELMSSON,J.-A.GUSTAFSSON,M.CARLQUIST JRNL TITL THE THREE-DIMENSIONAL STRUCTURE OF THE LIVER X JRNL TITL 2 RECEPTOR BETA REVEALS A FLEXIBLE LIGAND-BINDING JRNL TITL 3 POCKET THAT CAN ACCOMMODATE FUNDAMENTALLY JRNL TITL 4 DIFFERENT LIGANDS. JRNL REF J.BIOL.CHEM. V. 278 38821 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12819202 JRNL DOI 10.1074/JBC.M304842200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 25718 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1381 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1831 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7477 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : 1.29000 REMARK 3 B33 (A**2) : -1.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.410 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.305 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.914 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7745 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 7177 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10502 ; 1.490 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16631 ; 0.842 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 908 ; 5.804 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1189 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8385 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1612 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1833 ; 0.215 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 8222 ; 0.224 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 4710 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 208 ; 0.180 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 20 ; 0.205 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 81 ; 0.243 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4613 ; 0.581 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7458 ; 1.145 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3132 ; 1.659 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3044 ; 3.050 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 1PQC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-03. REMARK 100 THE RCSB ID CODE IS RCSB019497.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MAXFLUX CONFOCAL MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27153 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: THYROID HORMONE RECEPTOR BETA LIGAND BINDING REMARK 200 DOMAIN REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ISOPROPANOL, PEG 4000, HEPES, REMARK 280 GLYCEROL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 292K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.36100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.00100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.63100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.00100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.36100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.63100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 42760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -58.72200 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -103.26200 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 209 REMARK 465 SER A 210 REMARK 465 HIS A 211 REMARK 465 MET A 212 REMARK 465 GLY A 213 REMARK 465 GLU A 214 REMARK 465 GLY A 215 REMARK 465 GLU A 216 REMARK 465 GLY A 217 REMARK 465 VAL A 218 REMARK 465 GLN A 219 REMARK 465 LEU A 254 REMARK 465 GLY A 255 REMARK 465 ALA A 256 REMARK 465 ASP A 257 REMARK 465 PRO A 258 REMARK 465 GLN A 259 REMARK 465 SER A 260 REMARK 465 VAL A 459 REMARK 465 HIS A 460 REMARK 465 GLU A 461 REMARK 465 GLY B 209 REMARK 465 SER B 210 REMARK 465 HIS B 211 REMARK 465 MET B 212 REMARK 465 GLY B 213 REMARK 465 GLU B 214 REMARK 465 GLY B 215 REMARK 465 GLU B 216 REMARK 465 GLY B 217 REMARK 465 VAL B 218 REMARK 465 GLN B 259 REMARK 465 SER B 260 REMARK 465 VAL B 459 REMARK 465 HIS B 460 REMARK 465 GLU B 461 REMARK 465 GLY C 209 REMARK 465 SER C 210 REMARK 465 HIS C 211 REMARK 465 MET C 212 REMARK 465 GLY C 213 REMARK 465 GLU C 214 REMARK 465 GLY C 215 REMARK 465 GLU C 216 REMARK 465 GLY C 217 REMARK 465 VAL C 218 REMARK 465 GLN C 219 REMARK 465 SER C 244 REMARK 465 ASP C 245 REMARK 465 GLN C 246 REMARK 465 PRO C 247 REMARK 465 GLY C 255 REMARK 465 ALA C 256 REMARK 465 ASP C 257 REMARK 465 PRO C 258 REMARK 465 VAL C 459 REMARK 465 HIS C 460 REMARK 465 GLU C 461 REMARK 465 GLY D 209 REMARK 465 SER D 210 REMARK 465 HIS D 211 REMARK 465 MET D 212 REMARK 465 GLY D 213 REMARK 465 GLU D 214 REMARK 465 GLY D 215 REMARK 465 GLU D 216 REMARK 465 GLY D 217 REMARK 465 VAL D 218 REMARK 465 GLN D 219 REMARK 465 PHE D 243 REMARK 465 SER D 244 REMARK 465 ASP D 245 REMARK 465 GLN D 246 REMARK 465 PRO D 247 REMARK 465 LYS D 248 REMARK 465 PRO D 253 REMARK 465 LEU D 254 REMARK 465 GLY D 255 REMARK 465 ALA D 256 REMARK 465 ASP D 257 REMARK 465 PRO D 258 REMARK 465 GLN D 259 REMARK 465 LEU D 330 REMARK 465 LYS D 331 REMARK 465 ASP D 332 REMARK 465 LEU D 444 REMARK 465 GLN D 445 REMARK 465 ASP D 446 REMARK 465 LYS D 447 REMARK 465 VAL D 459 REMARK 465 HIS D 460 REMARK 465 GLU D 461
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 261 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 219 CG CD OE1 NE2 REMARK 470 ARG B 261 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 330 CG CD1 CD2 REMARK 470 LEU C 254 CG CD1 CD2 REMARK 470 SER D 260 OG REMARK 470 ARG D 261 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 329 CG CD1 CD2 CE1 CE2 CZ
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 437 O HOH B 50 2.16 REMARK 500 OG SER D 242 OE2 GLU D 281 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 284 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP B 332 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 338 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 262 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 299 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 243 36.62 -143.55 REMARK 500 LEU A 293 1.36 -68.24 REMARK 500 GLN A 346 153.85 -48.68 REMARK 500 PHE A 379 53.68 -97.97 REMARK 500 GLU A 388 68.01 -119.84 REMARK 500 GLN A 445 41.40 -96.50 REMARK 500 ASP A 446 42.56 30.91 REMARK 500 LYS A 447 78.69 -110.47 REMARK 500 ASP B 257 -162.09 -79.79 REMARK 500 LYS B 331 -50.34 89.60 REMARK 500 PRO C 253 84.17 -57.30 REMARK 500 THR C 328 76.29 -112.87 REMARK 500 ILE C 409 -74.46 -97.57 REMARK 500 LYS C 410 -74.94 -17.71 REMARK 500 ASP C 414 70.79 -100.25 REMARK 500 ASP C 446 27.13 49.19 REMARK 500 ARG D 241 -34.42 -36.44 REMARK 500 ARG D 261 -87.21 -80.22 REMARK 500 PHE D 379 48.77 -85.92 REMARK 500 GLU D 388 70.51 -116.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS C 248 VAL C 249 -142.90 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 A 1500 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 B 2500 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 C 3500 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 D 4500
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PQ9 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH THE SAME LIGAND BUT WITH REMARK 900 THE LIGAND INTACT REMARK 900 RELATED ID: 1PQ6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GW3965
DBREF 1PQC A 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQC B 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQC C 213 461 UNP P55055 NR1H2_HUMAN 213 461 DBREF 1PQC D 213 461 UNP P55055 NR1H2_HUMAN 213 461
SEQADV 1PQC GLY A 209 UNP P55055 INSERTION SEQADV 1PQC SER A 210 UNP P55055 INSERTION SEQADV 1PQC HIS A 211 UNP P55055 INSERTION SEQADV 1PQC MET A 212 UNP P55055 INSERTION SEQADV 1PQC GLY B 209 UNP P55055 INSERTION SEQADV 1PQC SER B 210 UNP P55055 INSERTION SEQADV 1PQC HIS B 211 UNP P55055 INSERTION SEQADV 1PQC MET B 212 UNP P55055 INSERTION SEQADV 1PQC GLY C 209 UNP P55055 INSERTION SEQADV 1PQC SER C 210 UNP P55055 INSERTION SEQADV 1PQC HIS C 211 UNP P55055 INSERTION SEQADV 1PQC MET C 212 UNP P55055 INSERTION SEQADV 1PQC GLY D 209 UNP P55055 INSERTION SEQADV 1PQC SER D 210 UNP P55055 INSERTION SEQADV 1PQC HIS D 211 UNP P55055 INSERTION SEQADV 1PQC MET D 212 UNP P55055 INSERTION
SEQRES 1 A 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 A 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 A 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 A 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 A 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 A 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 A 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 A 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 A 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 A 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 A 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 A 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 A 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 A 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 A 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 A 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 A 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 A 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 A 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 A 253 ILE TRP ASP VAL HIS GLU SEQRES 1 B 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 B 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 B 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 B 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 B 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 B 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 B 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 B 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 B 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 B 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 B 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 B 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 B 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 B 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 B 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 B 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 B 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 B 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 B 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 B 253 ILE TRP ASP VAL HIS GLU SEQRES 1 C 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 C 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 C 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 C 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 C 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 C 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 C 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 C 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 C 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 C 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 C 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 C 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 C 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 C 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 C 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 C 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 C 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 C 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 C 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 C 253 ILE TRP ASP VAL HIS GLU SEQRES 1 D 253 GLY SER HIS MET GLY GLU GLY GLU GLY VAL GLN LEU THR SEQRES 2 D 253 ALA ALA GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA SEQRES 3 D 253 GLN LEU GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO SEQRES 4 D 253 LYS VAL THR PRO TRP PRO LEU GLY ALA ASP PRO GLN SER SEQRES 5 D 253 ARG ASP ALA ARG GLN GLN ARG PHE ALA HIS PHE THR GLU SEQRES 6 D 253 LEU ALA ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA SEQRES 7 D 253 LYS GLN VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP SEQRES 8 D 253 GLN ILE ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET SEQRES 9 D 253 LEU LEU GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU SEQRES 10 D 253 CYS ILE THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP SEQRES 11 D 253 ASP PHE HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN SEQRES 12 D 253 PRO ILE PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY SEQRES 13 D 253 LEU ASP ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN SEQRES 14 D 253 ILE PHE SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY SEQRES 15 D 253 ARG VAL GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU SEQRES 16 D 253 LEU SER TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU SEQRES 17 D 253 ARG PHE PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG SEQRES 18 D 253 THR LEU SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU SEQRES 19 D 253 ARG LEU GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU SEQRES 20 D 253 ILE TRP ASP VAL HIS GLU
HET 444 A1500 31 HET 444 B2500 31 HET 444 C3500 31 HET 444 D4500 31
HETNAM 444 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1- HETNAM 2 444 HYDROXY-1-(TRIFLUOROMETHYL) HETNAM 3 444 ETHYL]PHENYL}BENZENESULFONAMIDE
FORMUL 5 444 4(C17 H12 F9 N O3 S) FORMUL 9 HOH *181(H2 O)
HELIX 1 1 THR A 221 SER A 244 1 24 HELIX 2 2 ARG A 261 LYS A 287 1 27 HELIX 3 3 GLY A 291 LEU A 295 5 5 HELIX 4 4 GLY A 296 ARG A 319 1 24 HELIX 5 5 LYS A 337 ALA A 343 1 7 HELIX 6 6 GLN A 346 GLY A 364 1 19 HELIX 7 7 ASP A 366 PHE A 379 1 14 HELIX 8 8 GLU A 388 ARG A 411 1 24 HELIX 9 9 LEU A 416 LEU A 444 1 29 HELIX 10 10 PRO A 450 ASP A 458 1 9 HELIX 11 11 THR B 221 ASN B 239 1 19 HELIX 12 12 ASN B 239 ASP B 245 1 7 HELIX 13 13 ARG B 261 VAL B 289 1 29 HELIX 14 14 GLY B 291 LEU B 295 5 5 HELIX 15 15 GLY B 296 ARG B 319 1 24 HELIX 16 16 LYS B 337 ALA B 343 1 7 HELIX 17 17 GLN B 346 GLY B 364 1 19 HELIX 18 18 ASP B 366 PHE B 379 1 14 HELIX 19 19 GLU B 388 ARG B 411 1 24 HELIX 20 20 LEU B 416 LEU B 444 1 29 HELIX 21 21 PRO B 450 ASP B 458 1 9 HELIX 22 22 THR C 221 ASN C 239 1 19 HELIX 23 23 SER C 260 GLN C 288 1 29 HELIX 24 24 GLY C 291 LEU C 295 5 5 HELIX 25 25 GLY C 296 ARG C 319 1 24 HELIX 26 26 SER C 336 ALA C 343 1 8 HELIX 27 27 GLN C 346 GLY C 364 1 19 HELIX 28 28 ASP C 366 PHE C 379 1 14 HELIX 29 29 GLU C 388 ARG C 411 1 24 HELIX 30 30 LEU C 416 LEU C 444 1 29 HELIX 31 31 PRO C 450 ASP C 458 1 9 HELIX 32 32 THR D 221 SER D 242 1 22 HELIX 33 33 SER D 260 VAL D 289 1 30 HELIX 34 34 GLY D 291 LEU D 295 5 5 HELIX 35 35 GLY D 296 ARG D 319 1 24 HELIX 36 36 SER D 336 ALA D 343 1 8 HELIX 37 37 GLN D 346 GLY D 364 1 19 HELIX 38 38 ASP D 366 PHE D 379 1 14 HELIX 39 39 GLU D 388 ARG D 411 1 24 HELIX 40 40 LEU D 416 ARG D 443 1 28 HELIX 41 41 PRO D 450 ASP D 458 1 9
SHEET 1 A 3 TYR A 320 ASN A 321 0 SHEET 2 A 3 CYS A 326 LEU A 330 -1 O CYS A 326 N ASN A 321 SHEET 3 A 3 PHE A 333 SER A 336 -1 O PHE A 333 N LEU A 330 SHEET 1 B 3 TYR B 320 ASN B 321 0 SHEET 2 B 3 CYS B 326 PHE B 329 -1 O CYS B 326 N ASN B 321 SHEET 3 B 3 PHE B 333 SER B 336 -1 O TYR B 335 N ILE B 327 SHEET 1 C 3 TYR C 320 ASN C 321 0 SHEET 2 C 3 CYS C 326 LEU C 330 -1 O CYS C 326 N ASN C 321 SHEET 3 C 3 PHE C 333 TYR C 335 -1 O TYR C 335 N ILE C 327 SHEET 1 D 2 TYR D 320 ASN D 321 0 SHEET 2 D 2 CYS D 326 ILE D 327 -1 O CYS D 326 N ASN D 321
SITE 1 AC1 15 PHE A 271 THR A 272 ALA A 275 MET A 312 SITE 2 AC1 15 THR A 316 PHE A 329 LEU A 345 PHE A 349 SITE 3 AC1 15 ILE A 353 HIS A 435 GLN A 438 LEU A 442 SITE 4 AC1 15 LEU A 449 LEU A 453 TRP A 457 SITE 1 AC2 17 PHE B 268 PHE B 271 ALA B 275 MET B 312 SITE 2 AC2 17 LEU B 313 THR B 316 PHE B 329 LEU B 345 SITE 3 AC2 17 PHE B 349 ILE B 353 HIS B 435 GLN B 438 SITE 4 AC2 17 VAL B 439 LEU B 442 LEU B 449 LEU B 453 SITE 5 AC2 17 TRP B 457 SITE 1 AC3 16 PHE C 268 PHE C 271 LEU C 274 ALA C 275 SITE 2 AC3 16 MET C 312 LEU C 313 THR C 316 LEU C 345 SITE 3 AC3 16 PHE C 349 ILE C 353 HIS C 435 GLN C 438 SITE 4 AC3 16 LEU C 442 LEU C 449 LEU C 453 TRP C 457 SITE 1 AC4 16 PHE D 268 PHE D 271 LEU D 274 ALA D 275 SITE 2 AC4 16 ILE D 309 MET D 312 LEU D 313 THR D 316 SITE 3 AC4 16 TYR D 335 LEU D 345 PHE D 349 ILE D 353 SITE 4 AC4 16 HIS D 435 GLN D 438 LEU D 449 TRP D 457
CRYST1 58.722 103.262 176.002 90.00 90.00 90.00 P 21 21 21 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017029 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009684 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005682 0.00000